Still can not get any traction
Big losing qtr. No FDA movement for Mcopaxone. Mngnt paying themselves handsomly. expences way up burn thru 90-100 mill in cash this year alone with no closer to new product into. until maybe late 2015- at least the copaxone patents will expire by then.
Sentiment: Sell